Back
Regulus Therapeutics Stock Predictions
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
30
RGLS
Regulus Therapeutics
Last Price:
$1.54
Seasonality Move:
7.82%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.Regulus Therapeutics Stock Forecast
-
Is Regulus Therapeutics Stock Undervalued?The current Regulus Therapeutics [RGLS] share price is $1.54. The Score for RGLS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
RGLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Regulus Therapeutics Stock Go Up Next Year?
Data Unavailable
Regulus Therapeutics Stock Rating
Data Unavailable
Regulus Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regulusrx.com
52-Week Data
52-Week High:
3.79
52-Week Low:
1.08
Prediction Charts
Market Cap:
100.9M
Price in USD:
1.54
Volume:
46K
Beta:
1.69
Technical Analysis
SMA50:
1.53
SMA100:
1.56
SMA200:
1.89
52-Wk Change:
17.56%
Stock Predictions
-
Is Regulus Therapeutics stock public?Yes, Regulus Therapeutics is a publicly traded company.
-
What is the Regulus Therapeutics stock quote today?The Regulus Therapeutics stock price is 1.54 USD today.
-
How to buy Regulus Therapeutics stock online?You can buy Regulus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-5 | 1.59 | 1.51 | 1.63 | 1.50 |
| Dec-6 | 1.53 | 1.60 | 1.61 | 1.52 |
| Dec-9 | 1.60 | 1.57 | 1.64 | 1.56 |
| Dec-10 | 1.57 | 1.64 | 1.70 | 1.56 |
| Dec-11 | 1.69 | 1.70 | 1.77 | 1.62 |
| Dec-12 | 1.69 | 1.60 | 1.69 | 1.57 |
| Dec-13 | 1.60 | 1.58 | 1.65 | 1.52 |
| Dec-16 | 1.57 | 1.64 | 1.70 | 1.57 |
| Dec-17 | 1.60 | 1.62 | 1.65 | 1.53 |
| Dec-18 | 1.63 | 1.51 | 1.64 | 1.50 |
| Dec-19 | 1.54 | 1.55 | 1.65 | 1.50 |
| Dec-20 | 1.53 | 1.59 | 1.60 | 1.51 |
| Dec-23 | 1.57 | 1.53 | 1.59 | 1.49 |
| Dec-24 | 1.53 | 1.54 | 1.54 | 1.51 |
Regulus Therapeutics Earnings
Data Unavailable
Regulus Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and a decrease next year of $0.48 per share.
* Regulus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.